Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
The Submaximal Clinical Exercise Tolerance Test (SXTT) to Establish Safe Exercise Prescription Parameters for Patients with Chronic Disease and Disability.
Paediatric acquired demyelinating syndromes: incidence, clinical and magnetic resonance imaging features.
Epidermal pigmentation in the human lineage is an adaptation to ultraviolet radiation.
Multiple sclerosis causing a partial sixth nerve palsy.
Organic solvents as risk factor for autoimmune diseases: a systematic review and meta-analysis.
Impact of Cigarette Smoking on Conversion from Clinically Isolated Syndrome to Clinically Definite Multiple Sclerosis.
MP2RAGE Multiple Sclerosis Magnetic Resonance Imaging at 3 T.
Disease-modifying drugs for multiple sclerosis and JC virus expression.
Clinical correlates of chronic cerebrospinal venous insufficiency in multiple sclerosis.
[Cognitive impairment in demyelinating disease].
Modeling of cognitive impairment by disease duration in multiple sclerosis: a cross-sectional study.
Safety, tolerability, and efficacy of orally administered cannabinoids in MS.
The role of laquinimod in modulation of the immune response in relapsing-remitting multiple sclerosis: Lessons from gene expression signatures.
miRNA in multiple sclerosis: search for novel biomarkers.
Momenta Pharmaceuticals Announces Launch of Glatopa(TM) (glatiramer acetate injection), the First Substitutable Generic for COPAXONE(R) (glatiramer acetate injection) 20mg
Delayed onset adenosine deaminase deficiency associated with acute disseminated encephalomyelitis.
Psoriasis during natalizumab treatment for multiple sclerosis.
Clinical effects of natalizumab on multiple sclerosis appear early in treatment course.
Whole-Brain Diffusion Tensor Imaging in Correlation to Visual-Evoked Potentials in Multiple Sclerosis: A Tract-Based Spatial Statistics Analysis.
Age-dependent effects on the treatment response of natalizumab in MS patients.
Multiple sclerosis and oligodendroglioma: an exceptional association.
Twin studies and the heritability of MS: a conclusion.
Magnetic Resonance Phase Alterations in Multiple Sclerosis Patients with Short and Long Disease Duration.
Assessment of cerebral venous return by a novel plethysmography method.
Sexual dysfunction ın multiple sclerosis: Gender differences.
Pages
« first
‹ previous
…
121
122
123
124
125
126
127
128
129
…
next ›
last »